FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Warning on Dr. Bernes Eye Drops

FDA issues a warning against using Dr. Bernes MSM Drops 5% Solution and LightEyez MSM Eye Drops Eye Repair due to bacterial or fungal contamination....

latest-news-card-1
Federal Register

Comments Extended on Cell, Gene Therapies

Federal Register notice: FDA extends the comment period for a 7/14 notice that announced the availability of a draft guidance entitled Manufacturing C...

latest-news-card-1
Federal Register

Workshop on Clinical Study Diversity

Federal Register notice: FDA announces an 11/29-30 public workshop entitled Workshop to Enhance Clinical Study Diversity.

latest-news-card-1
Medical Devices

Draeger Recalls Carina Ventilators

Draeger Medical recalls its Carina Sub-Acute Care Ventilators due to the presence of contaminants in the devices airpath.

latest-news-card-1
Medical Devices

Dingell Concerned About TB from Bone Grafts

Rep. Debbie Dingell asks FDA and CDC to answer questions about recent cases of tuberculosis linked to contaminated Aziyo Biologics bone grafts.

latest-news-card-1
Human Drugs

Changes Sought in FDA Diabetes Endpoint Guidance

Three stakeholders make suggestions to an FDA draft guidance on efficacy endpoints in clinical trials for antidiabetic drugs.

latest-news-card-1
Human Drugs

Lillys Retevmo Hits Phase 3 Trial PFS Endpoint

Lilly says its Retevmo met the primary progression-free survival endpoint in a clinical trial in patients with RET-mutant medullary thyroid cancer.

latest-news-card-1
Medical Devices

Welldoc Insulin Dose Calculator Clearance

FDA clears a Welldoc 510(k) for its BlueStar diabetes digital health device that provides bolus insulin dose recommendations based on readings from co...

latest-news-card-1
Human Drugs

FDA Orphan Status for Multiple Myeloma Therapy

FDA grants Nexcella an orphan drug designation for its CAR-T cell therapy NXC-201 for treating multiple myeloma.

latest-news-card-1
Human Drugs

Objectionable Conditions in Clinical Investigation

FDA warns Angela Stupi in Cranberry Twp., PA, about violations in her conduct of two trials with investigational drugs.